The landscape of dementia analysis has developed radically with the appearance of subtle biomarkers, including amyloid PET scans, tau imaging, and blood-based checks that may detect Alzheimer's pathology many years just before signs and symptoms arise. Though these technological innovations stand for remarkable development in understanding neurodegenerative ailments, they've not https://epelio631mve0.wikinewspaper.com/user